P2B-127

Blokhin Cancer Research Center (Moscow, Russia) › P2B-127

P2B-127

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Blokhin Cancer Research Center (Moscow, Russia) · Dr. Moreau
consented 2013-06-27

completed

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 3 leukopenia with onset in cycle 2 (2013-08-16); assessed as related to study drug (probable); resolved 2013-08-21.

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.